Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)-Reference-Cited by-同舟云学术

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)

Published:2018-04 Issue: Volume:198 Page:152-159
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Bergmeijer Thomas O.,Reny Jean-Luc,Pakyz Ruth E.,Gong Li,Lewis Joshua P.,Kim Eun-Young,Aradi Daniel,Fernandez-Cadenas Israel,Horenstein Richard B.,Lee Ming Ta Michael,Whaley Ryan M.,Montaner Joan,Gensini Gian Franco,Cleator John H.,Chang Kiyuk,Holmvang Lene,Hochholzer Willibald,Roden Dan M.,Winter Stefan,Altman Russ B.,Alexopoulos Dimitrios,Kim Ho-Sook,Déry Jean-Pierre,Gawaz Meinrad,Bliden Kevin,Valgimigli Marco,Marcucci Rossella,Campo Gianluca,Schaeffeler Elke,Dridi Nadia P.,Wen Ming-Shien,Shin Jae Gook,Simon Tabassome,Fontana Pierre,Giusti Betti,Geisler Tobias,Kubo Michiaki,Trenk Dietmar,Siller-Matula Jolanta M.,ten Berg Jurriën M.,Gurbel Paul A.,Hulot Jean-Sebastien,Mitchell Braxton D.,Schwab Matthias,Ritchie Marylyn DeRiggi,Klein Teri E.,Shuldiner Alan R.

Funder

National Heart, Lung, and Blood Institute of the National Institutes of Health

NIH National Institute of General Medical Sciences

NIH

National Health Research Institut

National Science Council

Chang Gung Memorial Hospital

NRPB

Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. 2014 ESC/EACTS guidelines on myocardial revascularization;Windecker;EuroIntervention,2015

2. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: A report of the American College of cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;Circulation,2011

3. Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: a nationwide Swedish registry report;Grimfjard;Am Heart J,2016

4. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

5. Efficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials;Chen;PLoS One,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. EXPRESSION OF VARIABILITY OF THE CYP2C19*2 GENE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION FROM A SOUTH AMERICAN HOSPITAL AND ITS FUTURE RELEVANCE IN THE INTERACTION BETWEEN GENETICS AND CARDIOLOGY;2023-08-20

3. The Potential Impact of Preemptive Pharmacogenetic Genotyping in the Neonatal Intensive Care Unit;The Journal of Pediatrics;2023-08

4. Pharmacogenetics of Antiplatelet Therapy;Annual Review of Pharmacology and Toxicology;2023-01-20

5. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association;Circulation;2022-08-23